GERN – Geron Corporation
Geron CorporationGERN
$1.46Name : Geron Corporation
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $931,504,896.00
EPSttm : -0.13
Geron Corporation
$1.46
2.10%$0.03Float Short %
12.76
Margin Of Safety %
Put/Call OI Ratio
0.11
EPS Next Q Diff
-0.01
EPS Last/This Y
0.16
EPS This/Next Y
0.1
Price
1.46
Target Price
3.62
Analyst Recom
2
Performance Q
-1.35
Relative Volume
0.55
Beta
0.61
Ticker: GERN
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | GERN | 1.255 | 0.13 | 0.00 | 85719 |
| 2025-07-28 | GERN | 1.14 | 0.13 | 0.06 | 85794 |
| 2025-07-29 | GERN | 1.135 | 0.13 | 0.11 | 86515 |
| 2025-07-30 | GERN | 1.095 | 0.13 | 0.47 | 87018 |
| 2025-07-31 | GERN | 1.145 | 0.10 | 0.13 | 80436 |
| 2025-08-01 | GERN | 1.175 | 0.10 | 0.01 | 80748 |
| 2025-08-04 | GERN | 1.22 | 0.10 | 0.06 | 82555 |
| 2025-08-05 | GERN | 1.205 | 0.10 | 0.01 | 82863 |
| 2025-08-06 | GERN | 1.385 | 0.10 | 0.02 | 83863 |
| 2025-08-07 | GERN | 1.305 | 0.09 | 0.13 | 88323 |
| 2025-08-08 | GERN | 1.28 | 0.10 | 0.18 | 88380 |
| 2025-08-11 | GERN | 1.355 | 0.10 | 0.08 | 88222 |
| 2025-08-12 | GERN | 1.345 | 0.10 | 0.50 | 90336 |
| 2025-08-13 | GERN | 1.425 | 0.10 | 0.10 | 90708 |
| 2025-08-14 | GERN | 1.455 | 0.10 | 0.08 | 91675 |
| 2025-08-15 | GERN | 1.455 | 0.10 | 0.05 | 92457 |
| 2025-08-18 | GERN | 1.445 | 0.10 | 0.11 | 89177 |
| 2025-08-19 | GERN | 1.425 | 0.10 | 0.41 | 90227 |
| 2025-08-20 | GERN | 1.385 | 0.10 | 0.56 | 90838 |
| 2025-08-21 | GERN | 1.425 | 0.11 | 0.17 | 91567 |
| 2025-08-22 | GERN | 1.455 | 0.11 | 0.07 | 92438 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | GERN | 1.26 | 71.5 | 43.8 | -0.13 |
| 2025-07-28 | GERN | 1.15 | 69.2 | 51.9 | -0.13 |
| 2025-07-29 | GERN | 1.13 | 69.2 | 43.6 | -0.13 |
| 2025-07-30 | GERN | 1.10 | 69.2 | 45.3 | -0.13 |
| 2025-07-31 | GERN | 1.15 | 69.2 | 36.6 | -0.13 |
| 2025-08-01 | GERN | 1.17 | 67.2 | 40.1 | -0.14 |
| 2025-08-04 | GERN | 1.21 | 67.2 | 38.6 | -0.14 |
| 2025-08-05 | GERN | 1.20 | 67.2 | 43.1 | -0.14 |
| 2025-08-06 | GERN | 1.38 | 67.2 | 24.3 | -0.14 |
| 2025-08-07 | GERN | 1.30 | 67.2 | 49.0 | -0.14 |
| 2025-08-08 | GERN | 1.28 | 67.2 | -6.6 | -0.12 |
| 2025-08-11 | GERN | 1.36 | 31.3 | -14.0 | -0.12 |
| 2025-08-12 | GERN | 1.35 | 31.3 | -7.4 | -0.11 |
| 2025-08-13 | GERN | 1.43 | 31.3 | -13.9 | -0.11 |
| 2025-08-14 | GERN | 1.46 | 31.3 | -10.1 | -0.11 |
| 2025-08-15 | GERN | 1.46 | 31.3 | -8.8 | -0.11 |
| 2025-08-18 | GERN | 1.44 | 16.7 | -7.5 | -0.11 |
| 2025-08-19 | GERN | 1.43 | 16.7 | -7.4 | -0.11 |
| 2025-08-20 | GERN | 1.38 | 16.7 | -5.1 | -0.11 |
| 2025-08-21 | GERN | 1.42 | 16.7 | -10.5 | -0.11 |
| 2025-08-22 | GERN | 1.46 | 16.7 | -10.1 | -0.11 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | GERN | 0.42 | 5.23 | 11.26 |
| 2025-07-28 | GERN | 0.42 | 4.99 | 11.26 |
| 2025-07-29 | GERN | 0.42 | 4.99 | 11.26 |
| 2025-07-30 | GERN | 0.42 | 4.99 | 11.26 |
| 2025-07-31 | GERN | 0.42 | 4.99 | 11.26 |
| 2025-08-01 | GERN | 0.42 | 4.99 | 11.26 |
| 2025-08-04 | GERN | 0.42 | 6.61 | 11.26 |
| 2025-08-05 | GERN | 0.42 | 6.61 | 11.26 |
| 2025-08-06 | GERN | 0.42 | 6.61 | 11.26 |
| 2025-08-07 | GERN | 0.42 | 6.61 | 11.26 |
| 2025-08-08 | GERN | 0.42 | 6.61 | 11.26 |
| 2025-08-11 | GERN | 0.42 | 6.56 | 11.23 |
| 2025-08-12 | GERN | 0.43 | 6.56 | 12.75 |
| 2025-08-13 | GERN | 0.43 | 6.56 | 12.75 |
| 2025-08-14 | GERN | 0.42 | 6.56 | 12.76 |
| 2025-08-15 | GERN | 0.42 | 6.56 | 12.76 |
| 2025-08-18 | GERN | 0.44 | 5.63 | 12.73 |
| 2025-08-19 | GERN | 0.44 | 5.63 | 12.76 |
| 2025-08-20 | GERN | 0.42 | 5.63 | 12.76 |
| 2025-08-21 | GERN | 0.42 | 5.63 | 12.76 |
| 2025-08-22 | GERN | 0.42 | 5.63 | 12.76 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.02
Avg. EPS Est. Current Quarter
-0.03
Avg. EPS Est. Next Quarter
-0.03
Insider Transactions
0.42
Institutional Transactions
5.63
Beta
0.61
Average Sales Estimate Current Quarter
55
Average Sales Estimate Next Quarter
62
Fair Value
Quality Score
47
Growth Score
56
Sentiment Score
26
Actual DrawDown %
72.7
Max Drawdown 5-Year %
-78.4
Target Price
3.62
P/E
Forward P/E
PEG
P/S
5.66
P/B
3.59
P/Free Cash Flow
EPS
-0.13
Average EPS Est. Cur. Y
-0.11
EPS Next Y. (Est.)
-0.02
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-53.52
Relative Volume
0.55
Return on Equity vs Sector %
-58.6
Return on Equity vs Industry %
-45.7
EPS 1 7Days Diff
EPS 1 30Days Diff
0.01
EBIT Estimation
-10.1
Geron CorporationSector: Healthcare
Industry: Biotechnology
Employees: 229
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
stock quote shares GERN – Geron Corporation Stock Price stock today
news today GERN – Geron Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch GERN – Geron Corporation yahoo finance google finance
stock history GERN – Geron Corporation invest stock market
stock prices GERN premarket after hours
ticker GERN fair value insiders trading